Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities.

Cox FM, Titulaer MJ, Sont JK, Wintzen AR, Verschuuren JJ, Badrising UA.

Brain. 2011 Nov;134(Pt 11):3167-75. doi: 10.1093/brain/awr217. Epub 2011 Sep 9.

PMID:
21908393
2.

Magnetic resonance imaging of skeletal muscles in sporadic inclusion body myositis.

Cox FM, Reijnierse M, van Rijswijk CS, Wintzen AR, Verschuuren JJ, Badrising UA.

Rheumatology (Oxford). 2011 Jun;50(6):1153-61. doi: 10.1093/rheumatology/ker001. Epub 2011 Feb 2.

PMID:
21288962
3.

Myotonic dystrophy: the burden for patients and their partners.

Timman R, Tibben A, Wintzen AR.

J Rehabil Med. 2010 Oct;42(9):823-30. doi: 10.2340/16501977-0598.

4.

The heart in sporadic inclusion body myositis: a study in 51 patients.

Cox FM, Delgado V, Verschuuren JJ, Ballieux BE, Bax JJ, Wintzen AR, Badrising UA.

J Neurol. 2010 Mar;257(3):447-51. doi: 10.1007/s00415-009-5350-9. Epub 2009 Oct 8.

5.

The effect of plasma from muscle-specific tyrosine kinase myasthenia patients on regenerating endplates.

ter Beek WP, Martínez-Martínez P, Losen M, de Baets MH, Wintzen AR, Verschuuren JJ, Niks EH, van Duinen SG, Vincent A, Molenaar PC.

Am J Pathol. 2009 Oct;175(4):1536-44. doi: 10.2353/ajpath.2009.090040. Epub 2009 Sep 10.

6.

Detecting dysphagia in inclusion body myositis.

Cox FM, Verschuuren JJ, Verbist BM, Niks EH, Wintzen AR, Badrising UA.

J Neurol. 2009 Dec;256(12):2009-13. doi: 10.1007/s00415-009-5229-9. Epub 2009 Jul 15.

7.

Association of the leukocyte immunoglobulin G (Fcgamma) receptor IIIa-158V/F polymorphism with inflammatory myopathies in Dutch patients.

Bronner IM, Hoogendijk JE, de Visser M, van de Vlekkert J, Badrising UA, Wintzen AR, Uitdehaag BM, Blokland-Fromme M, Leusen JH, van der Pol WL.

Tissue Antigens. 2009 Jun;73(6):586-9. doi: 10.1111/j.1399-0039.2009.01236.x.

PMID:
19493236
8.

Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1.

Niks EH, van Leeuwen Y, Leite MI, Dekker FW, Wintzen AR, Wirtz PW, Vincent A, van Tol MJ, Jol-van der Zijde CM, Verschuuren JJ.

J Neuroimmunol. 2008 Mar;195(1-2):151-6. doi: 10.1016/j.jneuroim.2008.01.013. Epub 2008 Apr 1.

PMID:
18384886
9.

Re: Lambert-Eaton myasthenic syndrome with pure ocular weakness.

Titulaer MJ, Wirtz PW, Wintzen AR, Verschuuren JJ.

Neurology. 2008 Jan 1;70(1):86; author reply 86-7. doi: 10.1212/01.wnl.0000295708.62369.59. No abstract available.

PMID:
18166715
10.

Limb-girdle muscular dystrophy in the Netherlands: gene defect identified in half the families.

van der Kooi AJ, Frankhuizen WS, Barth PG, Howeler CJ, Padberg GW, Spaans F, Wintzen AR, Wokke JH, van Ommen GJ, de Visser M, Bakker E, Ginjaar HB.

Neurology. 2007 Jun 12;68(24):2125-8.

PMID:
17562833
11.
12.

Synaptic dysfunction does not contribute to muscle weakness in inclusion-body myositis.

Badrising UA, Verschuuren JJ, Wintzen AR, van Dijk JG.

Muscle Nerve. 2007 Feb;35(2):266-7. No abstract available.

PMID:
17143892
13.

Inclusion body myositis. Clinical features and clinical course of the disease in 64 patients.

Badrising UA, Maat-Schieman ML, van Houwelingen JC, van Doorn PA, van Duinen SG, van Engelen BG, Faber CG, Hoogendijk JE, de Jager AE, Koehler PJ, de Visser M, Verschuuren JJ, Wintzen AR.

J Neurol. 2005 Dec;252(12):1448-54. Epub 2005 Jun 17.

PMID:
15942703
14.

Lambert-Eaton myasthenic syndrome has a more progressive course in patients with lung cancer.

Wirtz PW, Wintzen AR, Verschuuren JJ.

Muscle Nerve. 2005 Aug;32(2):226-9.

PMID:
15793845
15.

HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome.

Wirtz PW, Willcox N, van der Slik AR, Lang B, Maddison P, Koeleman BP, Giphart MJ, Wintzen AR, Roep BO, Verschuuren JJ.

J Neuroimmunol. 2005 Feb;159(1-2):230-7. Epub 2004 Dec 24.

PMID:
15652424
16.

Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis.

Badrising UA, Schreuder GM, Giphart MJ, Geleijns K, Verschuuren JJ, Wintzen AR, Maat-Schieman ML, van Doorn P, van Engelen BG, Faber CG, Hoogendijk JE, de Jager AE, Koehler PJ, de Visser M, van Duinen SG; Dutch IBM Study Group.

Neurology. 2004 Dec 28;63(12):2396-8.

PMID:
15623710
17.

Associated autoimmune diseases in patients with the Lambert-Eaton myasthenic syndrome and their families.

Wirtz PW, Bradshaw J, Wintzen AR, Verschuuren JJ.

J Neurol. 2004 Oct;251(10):1255-9.

PMID:
15503107
18.

The epidemiology of the Lambert-Eaton myasthenic syndrome in the Netherlands.

Wirtz PW, van Dijk JG, van Doorn PA, van Engelen BG, van der Kooi AJ, Kuks JB, Twijnstra A, de Visser M, Visser LH, Wokke JH, Wintzen AR, Verschuuren JJ.

Neurology. 2004 Jul 27;63(2):397-8. No abstract available.

PMID:
15277653
19.

HLA-B8 in patients with the Lambert-Eaton myasthenic syndrome reduces likelihood of associated small cell lung carcinoma.

Wirtz PW, Willcox N, Roep BO, Lang B, Wintzen AR, Newsom-Davis J, Verschuuren JJ.

Ann N Y Acad Sci. 2003 Sep;998:200-1. No abstract available.

PMID:
14592876
20.

[The clinical diagnosis 'wound botulism' in an injecting drug addict].

Verschuuren JJ, Wirtz PW, Wintzen AR, van Dijk JG.

Ned Tijdschr Geneeskd. 2003 Oct 4;147(40):1985-6; author reply 1986. Dutch. No abstract available.

PMID:
14574784
21.

High innate production of interleukin-10 and tumor necrosis factor-alpha contributes to susceptibility for non-paraneoplastic Lambert-Eaton myasthenic syndrome.

Wirtz PW, Huizinga TW, Stoeken DJ, Wintzen AR, Verschuuren JJ.

J Neuroimmunol. 2003 Jul;140(1-2):194-7.

PMID:
12864989
22.

The epidemiology of myasthenia gravis, Lambert-Eaton myasthenic syndrome and their associated tumours in the northern part of the province of South Holland.

Wirtz PW, Nijnuis MG, Sotodeh M, Willems LN, Brahim JJ, Putter H, Wintzen AR, Verschuuren JJ; Dutch Myasthenia Study Group.

J Neurol. 2003 Jun;250(6):698-701.

PMID:
12796832
23.

Necrotising myopathy, an unusual presentation of a steroid-responsive myopathy.

Bronner IM, Hoogendijk JE, Wintzen AR, van der Meulen MF, Linssen WH, Wokke JH, de Visser M.

J Neurol. 2003 Apr;250(4):480-5.

PMID:
12700915
24.

Difference in distribution of muscle weakness between myasthenia gravis and the Lambert-Eaton myasthenic syndrome.

Wirtz PW, Sotodeh M, Nijnuis M, Van Doorn PA, Van Engelen BG, Hintzen RQ, De Kort PL, Kuks JB, Twijnstra A, De Visser M, Visser LH, Wokke JH, Wintzen AR, Verschuuren JJ.

J Neurol Neurosurg Psychiatry. 2002 Dec;73(6):766-8.

25.

Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases.

Wirtz PW, Smallegange TM, Wintzen AR, Verschuuren JJ.

Clin Neurol Neurosurg. 2002 Sep;104(4):359-63.

PMID:
12140105
26.

Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo.

Badrising UA, Maat-Schieman ML, Ferrari MD, Zwinderman AH, Wessels JA, Breedveld FC, van Doorn PA, van Engelen BG, Hoogendijk JE, Höweler CJ, de Jager AE, Jennekens FG, Koehler PJ, de Visser M, Viddeleer A, Verschuuren JJ, Wintzen AR.

Ann Neurol. 2002 Mar;51(3):369-72.

PMID:
11891832
27.

HLA class I and II in Lambert-Eaton myasthenic syndrome without associated tumor.

Wirtz PW, Roep BO, Schreuder GM, van Doorn PA, van Engelen BG, Kuks JB, Twijnstra A, de Visser M, Visser LH, Wokke JH, Wintzen AR, Verschuuren JJ.

Hum Immunol. 2001 Aug;62(8):809-13.

PMID:
11476904
28.

Tonic pupils in Lambert-Eaton myasthenic syndrome.

Wirtz PW, de Keizer RJ, de Visser M, Wintzen AR, Verschuuren JJ.

Muscle Nerve. 2001 Mar;24(3):444-5. No abstract available.

PMID:
11353435
29.

[Proximal muscle weakness, depressed tendon reflexes and autonomic dysfunction: the Lambert-Eaton myasthenic syndrome].

Wirtz PW, Kuks JB, Wintzen AR, Verschuuren JJ.

Ned Tijdschr Geneeskd. 2001 Jan 13;145(2):57-61. Review. Dutch.

PMID:
11225256
30.

Neuropathy and IgM M-proteins: prognostic value of antibodies to MAG, SGPG, and sulfatide.

Eurelings M, Moons KG, Notermans NC, Sasker LD, De Jager AE, Wintzen AR, Wokke JH, Van den Berg LH.

Neurology. 2001 Jan 23;56(2):228-33.

PMID:
11160960
31.

Epidemiology of inclusion body myositis in the Netherlands: a nationwide study.

Badrising UA, Maat-Schieman M, van Duinen SG, Breedveld F, van Doorn P, van Engelen B, van den Hoogen F, Hoogendijk J, Höweler C, de Jager A, Jennekens F, Koehler P, van der Leeuw H, de Visser M, Verschuuren JJ, Wintzen AR.

Neurology. 2000 Nov 14;55(9):1385-7.

PMID:
11087787
32.

Acquired slow-channel syndrome: a form of myasthenia gravis with prolonged open time of the acetylcholine receptor channel.

Wintzen AR, Plomp JJ, Molenaar PC, van Dijk JG, van Kempen GT, Vos RM, Wokke JH, Vincent A.

Ann Neurol. 1998 Oct;44(4):657-64.

PMID:
9778265
33.

The calcium channel blocker verapamil in hypokalemic periodic paralysis.

Links TP, Arnoldus EP, Wintzen AR, van der Hoeven J, Gerritsen JJ, Brandenburg HC.

Muscle Nerve. 1998 Nov;21(11):1564-5. No abstract available.

PMID:
9771691
34.

['Inclusion body'-myositis].

Badrising UA, Maat-Schieman ML, van Duinen SG, van Dijk JG, Verschuuren JJ, Wintzen AR.

Ned Tijdschr Geneeskd. 1998 Mar 14;142(11):553-7. Dutch.

PMID:
9623110
35.

Very long chain acyl-coenzyme A dehydrogenase deficiency with adult onset.

Smelt AH, Poorthuis BJ, Onkenhout W, Scholte HR, Andresen BS, van Duinen SG, Gregersen N, Wintzen AR.

Ann Neurol. 1998 Apr;43(4):540-4.

PMID:
9546340
36.

Vocational perspectives and neuromuscular disorders.

Andries F, Wevers CW, Wintzen AR, Busch HF, Höweler CJ, de Jager AE, Padberg GW, de Visser M, Wokke JH.

Int J Rehabil Res. 1997 Sep;20(3):255-73.

PMID:
9331576
37.

[Gait impairment in the oldest old].

Bloem BR, Boers I, Lagaay AM, Haan J, Wintzen AR, Roos RA.

Tijdschr Gerontol Geriatr. 1997 Apr;28(2):76-81. Dutch.

PMID:
9221558
38.

Reversible severe myopathy during treatment with finasteride.

Haan J, Hollander JM, van Duinen SG, Saxena PR, Wintzen AR.

Muscle Nerve. 1997 Apr;20(4):502-4. No abstract available.

PMID:
9121510
39.

The clinical spectrum of limb girdle muscular dystrophy. A survey in The Netherlands.

van der Kooi AJ, Barth PG, Busch HF, de Haan R, Ginjaar HB, van Essen AJ, van Hooff LJ, Höweler CJ, Jennekens FG, Jongen P, Oosterhuis HJ, Padberg GW, Spaans F, Wintzen AR, Wokke JH, Bakker E, van Ommen GJ, Bolhuis PA, de Visser M.

Brain. 1996 Oct;119 ( Pt 5):1471-80.

PMID:
8931572
40.

Repetitive CMAPs: mechanisms of neural and synaptic genesis.

van Dijk JG, Lammers GJ, Wintzen AR, Molenaar PC.

Muscle Nerve. 1996 Sep;19(9):1127-33. Review.

PMID:
8761268
41.

[Fatal arrhythmia following administration of suxamethonium to a postpartum women who subsequently was found to have dystrophia myotonica].

Wintzen AR.

Ned Tijdschr Geneeskd. 1996 Aug 31;140(35):1783. Dutch. No abstract available.

PMID:
8927137
42.

[A patient with Creutzfeldt-Jakob disease following treatment with human growth hormone].

Roos RA, Wintzen AR, Will RG, Ironside JW, van Duinen SG.

Ned Tijdschr Geneeskd. 1996 Jun 1;140(22):1190-3. Dutch.

PMID:
8692356
43.

[For the present Duchenne' disease should not be treated with prednisone].

Jennekens FG, de Visser M, Wintzen AR, Wokke JH.

Ned Tijdschr Geneeskd. 1996 May 25;140(21):1109-11. Review. Dutch. No abstract available.

PMID:
8692335
44.

Risk of stroke during long-term anticoagulant therapy in patients after myocardial infarction.

Azar AJ, Koudstaal PJ, Wintzen AR, van Bergen PF, Jonker JJ, Deckers JW.

Ann Neurol. 1996 Mar;39(3):301-7.

PMID:
8602748
45.

Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves.

Shillito P, Molenaar PC, Vincent A, Leys K, Zheng W, van den Berg RJ, Plomp JJ, van Kempen GT, Chauplannaz G, Wintzen AR, et al.

Ann Neurol. 1995 Nov;38(5):714-22.

PMID:
7486862
46.

Optimal oral anticoagulant therapy in patients with mechanical heart valves.

Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJ, Vandenbroucke JP, Briët E.

N Engl J Med. 1995 Jul 6;333(1):11-7.

47.

Mutation in DHP receptor alpha 1 subunit (CACLN1A3) gene in a Dutch family with hypokalaemic periodic paralysis.

Boerman RH, Ophoff RA, Links TP, van Eijk R, Sandkuijl LA, Elbaz A, Vale-Santos JE, Wintzen AR, van Deutekom JC, Isles DE, et al.

J Med Genet. 1995 Jan;32(1):44-7.

48.

Influence of bolus volume on hyoid movements in normal individuals and patients with Parkinson's disease.

Wintzen AR, Badrising UA, Roos RA, Vielvoye J, Liauw L.

Can J Neurol Sci. 1994 Feb;21(1):57-9.

PMID:
8180907
49.

Dysphagia in ambulant patients with Parkinson's disease: common, not dangerous.

Wintzen AR, Badrising UA, Roos RA, Vielvoye J, Liauw L, Pauwels EK.

Can J Neurol Sci. 1994 Feb;21(1):53-6.

PMID:
8180906
50.

Aneurysmal bleeding. A plea for early surgery in good-risk patients.

Thomeer RT, Taal JC, Voormolen JH, Wintzen AR.

Acta Neurochir (Wien). 1994;128(1-4):126-31.

PMID:
7847128

Supplemental Content

Loading ...
Support Center